On the upside
Celgene (Nasdaq: CELG) reported positive trial results for its multiple myeloma treatment Revlimid. The biotechnology company also posted higher second quarter income that met expectations.
International Game Technology (NYSE: IGT) reported lower third quarter income but the results surpassed analyst expectations.
Although Hercules Offshore (Nasdaq: HERO) swung to a loss for the second quarter, the results were better than expected.
On the downside
Although second quarter earnings rose for Safeway (NYSE: SWY), the grocery chain lowered its full year forecast as sales slipped.
An insurance firm owned by billionaire Warren Buffett sold nearly 8 million shares of Moody's (NYSE: MCO) prompting a downgrade.
Celera (Nasdaq: CRA) disappointed with a second quarter revenue outlook below expectations and by withdrawing its full year revenue guidance.
In the broad market, advancing issues outpaced decliners by a margin of nearly 6 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks jumped 17 points to 545.
